» Articles » PMID: 18693812

Application of Artificial Neural Network-based Survival Analysis on Two Breast Cancer Datasets

Overview
Date 2008 Aug 13
PMID 18693812
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

This paper applies artificial neural networks (ANNs) to the survival analysis problem. Because ANNs can easily consider variable interactions and create a non-linear prediction model, they offer more flexible prediction of survival time than traditional methods. This study compares ANN results on two different breast cancer datasets, both of which use nuclear morphometric features. The results show that ANNs can successfully predict recurrence probability and separate patients with good (more than five years) and bad (less than five years) prognoses. Results are not as clear when the separation is done within subgroups such as lymph node positive or negative.

Citing Articles

Performance assessment of hybrid machine learning approaches for breast cancer and recurrence prediction.

Pati A, Panigrahi A, Parhi M, Giri J, Qin H, Mallik S PLoS One. 2024; 19(8):e0304768.

PMID: 39088457 PMC: 11293701. DOI: 10.1371/journal.pone.0304768.


Breast Cancer Prediction Using Fine Needle Aspiration Features and Upsampling with Supervised Machine Learning.

Shafique R, Rustam F, Choi G, Diez I, Mahmood A, Lipari V Cancers (Basel). 2023; 15(3).

PMID: 36765642 PMC: 9913345. DOI: 10.3390/cancers15030681.


Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology.

Raufaste-Cazavieille V, Santiago R, Droit A Front Mol Biosci. 2022; 9:962743.

PMID: 36304921 PMC: 9595279. DOI: 10.3389/fmolb.2022.962743.


Neural Networks for Survival Prediction in Medicine Using Prognostic Factors: A Review and Critical Appraisal.

Kantidakis G, Hazewinkel A, Fiocco M Comput Math Methods Med. 2022; 2022:1176060.

PMID: 36238497 PMC: 9553343. DOI: 10.1155/2022/1176060.


PSO-Based Evolutionary Approach to Optimize Head and Neck Biomedical Image to Detect Mesothelioma Cancer.

Praveen S, Tyagi N, Singh B, Karetla G, Thalor M, Joshi K Biomed Res Int. 2022; 2022:3618197.

PMID: 36033562 PMC: 9410819. DOI: 10.1155/2022/3618197.


References
1.
Love R, Duc N, Baumann L, Anh P, Van To T, Qian Z . Duration of signs and survival in premenopausal women with breast cancer. Breast Cancer Res Treat. 2004; 86(2):117-24. DOI: 10.1023/b:brea.0000032980.55245.c3. View

2.
West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R . Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A. 2001; 98(20):11462-7. PMC: 58752. DOI: 10.1073/pnas.201162998. View

3.
De Laurentiis M, Ravdin P . A technique for using neural network analysis to perform survival analysis of censored data. Cancer Lett. 1994; 77(2-3):127-38. DOI: 10.1016/0304-3835(94)90095-7. View

4.
De Laurentiis M, Ravdin P . Survival analysis of censored data: neural network analysis detection of complex interactions between variables. Breast Cancer Res Treat. 1994; 32(1):113-8. DOI: 10.1007/BF00666212. View

5.
Kappen H, Neijt J . Advanced ovarian cancer. Neural network analysis to predict treatment outcome. Ann Oncol. 1993; 4 Suppl 4:31-4. DOI: 10.1093/annonc/4.suppl_4.s31. View